Gum cordia: A novel matrix forming material for enteric resistant and sustained drug delivery - A technical note

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 330-333

  Mukherjee, Biswajit ^a   Dinda, Subas Chandra ^a   Barik, Bhakti Bhusan ^b  

^a JADAVPUR UNIVERSITY   (India)

^b UTKAL UNIVERSITY   (India)

Author keywords

Enteric resistant; Gum cordia; Sustained release tablet

Indexed keywords

DICLOFENAC; EXCIPIENT; GUM CORDIA; UNCLASSIFIED DRUG; VOVERAN SR 100; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTROLLED STUDY; DRUG SOLUBILITY; ENTERIC COATED TABLET; IN VITRO STUDY; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MANUFACTURE; TABLET MATRIX; TABLET THICKNESS; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG SCREENING; EVALUATION; GINGIVA; MATERIALS TESTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DIFFUSION; DRUG EVALUATION, PRECLINICAL; GINGIVA; MATERIALS TESTING; TABLETS, ENTERIC-COATED;

EID: 44849106162     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9051-y     Document Type: Article

References (14)

1. V. P. Pandey, R. Manavalan, S. Rajan, and K. S. Ganesh. Formulation and release characteristics of sustained release diltiazem hydrochloride tablet. Indian J. Pharm. Sci 65 1:44-48 (2003).
2. G. Yan, H. Li, R. Zhang, and D. Ding. Preparation and evaluation of a sustained release formulation of nefidipine HPMC tablets. Drug Dev. Ind. Pharm 26 6:681-686 (2000).
3. R. O. Williams 3rd, T. D. Reynolds, T. D. Cabelka, M. A. Sykara, and V. Mahaguna. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC. Pharm. Dev. Technol 7 2:181-93 (2002).
4. Q. R. Cao, Y. W. Choi, J. H. Cui, and B. J. Lee. Formulation release characteristics and bio-availability of novel monolithic HPMC matrix tablets containing acetaminofen. J. Control. Release 108 2-3:351-361 (2005).
5. T. Ishikawa, Y. Watanabe, K. Takayama, H. Endo, and M. Matsumoto. Effect of HPMC on the release profiles and bioavailability of poorly water soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm 202 1-2:173-178 (2000).
6. Y. M. Rao, J. K. Veni, and G. Javasagar. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev Ind Pharm 27 8:759-766 (2001).
7. G. V. Murli Mohan Babu, C. D. S. Prasad, K. Himasankar, V. Gourisankar, N. K. Kumar, and K. V. Ramanamurthy. Development of new controlled release formulation of flurbiprofen: In vitro-in vivo correlation. Indian J Pharm Sci 64 1:37-43 (2002).
8. G. V. Murli Mohan Babu, K. Himasankar, P. S. Cheruvu, and K. V. Ramanamurthy. Controlled release of diclofenac sodium by Gum karaya-Chitosan complex coacervate: In-vivo evaluation. Indian J. Pharm. Sci 63 5:408-412 (2001).
9. P. M. Morkhade, S. V. Fulgel, P. M. Satturwar, and S. B. Joshi. Gum Copal and Gum Damar: Novel matrix forming material for sustained drug delivery. Indian J. Pharm. Sci 68 1:53-58 (2006).
10. B. Mukherjee, and S. C. Dinda. New use of natural gum cordia and new modified gum cordia-As pharmaceutical excipients and a new modified gum cordia and its use for enteric resistant, sustained and controlled release agent and also as other pharmaceutical excipients. Indian Pat. Off. J 6 - 1: 14699 (2007).
11. A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor. The Pharmacological Basis of Therapeuticas, Vol. 1, 8th Edn, Pergamon, New York, U.S.A., 1991, p. 669.
12. The Indian Pharmacopoeia. Diclofenac sodium tablets. Govt. of India, Ministry of Health and Family Welfare, Vol-II, The Controller of Publication, New Delhi, India, 1996, p. 244.
13. The United States Pharmacopoeia (USP/NF). Physical tests/dissolution. The U. S. Pharmacopoeial Convention, Rackville, MD. 2002; 25/ 20:2011-2012.
14. The United States Pharmacopoeia (USP/NF). Official monographs/ diclofenac. The U. S. Pharmacopoeial Convention, Rackville, MD. 2002; 25/ 20:553-554.